Lexicon Pharmaceuticals
LXRX
#6176
Rank
ยฃ0.77 B
Marketcap
ยฃ1.75
Share price
1.30%
Change (1 day)
95.23%
Change (1 year)

Lexicon Pharmaceuticals (LXRX) - Net assets

Net assets on the balance sheet as of March 2026 : ยฃ0.15 Billion

According to Lexicon Pharmaceuticals 's latest financial reports the company has ยฃ0.15 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Lexicon Pharmaceuticals - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$ยฃ79.85 M-31.34%
2024-12-31$ยฃ0.11 B59.13%
2023-12-31$ยฃ73.08 M-24.51%
2022-12-31$ยฃ96.81 M15.04%
2021-12-31$ยฃ84.15 M-26.64%
2020-12-31$ยฃ0.11 B28.46%
2019-12-31$ยฃ89.3 M-529.29%
2018-12-31$-ยฃ20.81 Million-141.18%
2017-12-31$ยฃ50.51 M-60.4%
2016-12-31$ยฃ0.12 B-33.87%
2015-12-31$ยฃ0.19 B5.74%
2014-12-31$ยฃ0.18 B76.84%
2013-12-31$ยฃ0.10 B-37.48%
2012-12-31$ยฃ0.16 B-13.82%
2011-12-31$ยฃ0.19 B19.64%
2010-12-31$ยฃ0.16 B58.38%
2009-12-31$ยฃ0.10 B-24.38%
2008-12-31$ยฃ0.13 B-7.37%
2007-12-31$ยฃ0.14 B230.47%
2006-12-31$ยฃ43.65 M-12.27%
2005-12-31$ยฃ49.75 M-21.44%
2004-12-31$ยฃ63.33 M-31.84%
2003-12-31$ยฃ92.91 M-12.31%
2002-12-31$ยฃ0.10 B-29.64%
2001-12-31$ยฃ0.15 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Thermo Fisher Scientific
TMO
ยฃ39.06 B 25,564.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
ยฃ2.00 B 1,219.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
ยฃ23.58 B 15,390.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-ยฃ0.18 Billion-212.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.74 B 391.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.24 Billion-251.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-ยฃ0.13 Billion-180.84%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ4.66 B 2,962.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
ยฃ5.14 M-96.62%๐Ÿ‡บ๐Ÿ‡ธ USA